CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Verratti Mark Chief Operating Officer | Grant or award · Time-Based Stock Option | +146,933 | 146,933 | ||
| 2026-04-14 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −1,069 | $4.91 | $5K | 629,646 |
| 2026-03-22 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −2,055 | $4.58 | $9K | 630,715 |
| 2026-03-15 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −5,611 | $4.66 | $26K | 641,866 |
| 2026-03-15 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −9,096 | $4.66 | $42K | 632,770 |
| 2026-03-14 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −5,418 | $4.66 | $25K | 647,477 |
| 2026-03-13 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −9,164 | $4.66 | $43K | 652,895 |
| 2026-03-12 | Verratti Mark Chief Operating Officer | Grant or award | +247,423 | 662,059 | ||
| 2026-02-02 | Verratti Mark Chief Operating Officer | Grant or award | +32,810 | 414,636 | ||
| 2025-09-21 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −1,085 | $7.77 | $8K | 381,826 |
| 2025-04-30 | Verratti Mark Chief Operating Officer | Grant or award · Performance-Based Restricted Stock Units | +105,785 | 105,785 | ||
| 2025-04-14 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −1,085 | $8.08 | $9K | 382,911 |
| 2025-03-24 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −1,096 | $9.98 | $11K | 385,601 |
| 2025-03-24 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −1,605 | $9.98 | $16K | 383,996 |
| 2025-03-22 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −1,366 | $10.01 | $14K | 390,320 |
| 2025-03-22 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −3,623 | $10.01 | $36K | 386,697 |
| 2025-03-15 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −3,729 | $10.07 | $38K | 391,686 |
| 2025-03-14 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −5,847 | $10.07 | $59K | 395,415 |
| 2025-03-13 | Verratti Mark Chief Commercial Officer | Grant or award | +99,227 | 401,262 | ||
| 2025-02-07 | Verratti Mark Chief Commercial Officer | Grant or award | +12,758 | 302,035 |
Page 1 of 4 · 64 trades